|
CA2408124A1
|
|
Transgenically produced decorin
|
|
WO0126455A1
|
|
Methods of producing a target molecule in a transgenic animal and purification of the target molecule
|
|
WO0123525A2
|
|
Methods of producing cloned and transgenic mammals
|
|
BR0014527A
|
|
Transgenically produced fusion proteins
|
|
AU5657800A
|
|
Transgenic production of antibodies in milk
|
|
WO0069256A1
|
|
Transgenically produced antithrombin iii and mutants thereof
|
|
WO0061725A1
|
|
Method of purifying heterologous proteins
|
|
EP1127113A2
|
|
Transgenic and cloned mammals
|
|
CA2431859A1
|
|
Transgenic and cloned mammals
|
|
US6580017B1
|
|
Methods of reconstructed goat embryo transfer
|
|
WO9943389A1
|
|
Animal exposure masks
|
|
BR9812945A
|
|
Modified nucleic acid sequences and processes to increase mRNA levels and expression of cellular systems
|
|
US6073818A
|
|
Apparatus for controlled delivery of powdered solid materials
|
|
US6210736B1
|
|
Transgenically produced prolactin
|
|
EP0973934A1
|
|
Transgenically produced non-secreted proteins
|
|
US5896829A
|
|
Head-only animal exposure chambers
|
|
US6268487B1
|
|
Purification of biologically active peptides from milk
|
|
EP0773992A1
|
|
Transgenically produced antithrombin iii
|
|
WO9517085A1
|
|
Transgenic production of antibodies in milk
|
